Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Toxicology in Vitro

• Publication date

  2014-02-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.tiv.2013.10.013PMID 24184331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allergic contact dermatitis: a commentary on the relationship between T lymphocytes and skin sensitising potency.

  2012cited by this paper
• Putting the parts together: combining in vitro methods to test for skin sensitizing potentials.

  2012cited by this paper
• Elucidation of Xenobiotic Metabolism Pathways in Human Skin and Human Skin Models by Proteomic Profiling

  2012cited by this paper
• Determining epidermal disposition kinetics for use in an integrated nonanimal approach to skin sensitization risk assessment.

  2011cited by this paper
• Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment.

  2011cited by this paper
• Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010

  2011cited by this paper
• Integrating non-animal test information into an adaptive testing strategy - skin sensitization proof of concept case.

  2011cited by this paper
• Linalool – a significant contact sensitizer after air exposure

  2010cited by this paper
• Cytochrome P450-mediated activation of the fragrance compound geraniol forms potent contact allergens.

  2008cited by this paper
• Application of a Systems Biology Approach to Skin Allergy Risk Assessment

  2008cited by this paper
• Allergic contact dermatitis--formation, structural requirements, and reactivity of skin sensitizers.

  2008cited by this paper
• Sparse production but preferential incorporation of recently produced naïve T cells in the human peripheral pool

  2008cited by this paper
• Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review.

  2007cited by this paper
• Quantifying HTLV‐I dynamics

  2007cited by this paper
• A stochastic model of cytotoxic T cell responses.

  2004cited by this paper
• Molecular size as the main determinant of solute maximum flux across the skin.

  2004cited by this paper
• Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty

  2003cited by this paper
• Lineage relationship and protective immunity of memory CD8 T cell subsets

  2003cited by this paper
• Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways.

  2003cited by this paper
• Models of CD8+ responses: 1. What is the antigen-independent proliferation program.

  2003cited by this paper
• Contact allergy: the role of skin chemistry and metabolism

  2003cited by this paper
• A review of the scientific basis for uncertainty factors for use in quantitative risk assessment for the induction of allergic contact dermatitis

  2002cited by this paper
• Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells

  2001cited by this paper
• Immunology for physicists

  1997cited by this paper
• In vivo estimates of division and death rates of human T lymphocytes.

  1995cited by this paper
• Predicting Skin Permeability

  1992cited by this paper

• Exposome study for allergic diseases in children: Rationale and design of ECHO-COCOA study.

  2025cites this paper
• In Vitro Skin Models for Skin Sensitisation: Challenges and Future Directions

  2025cites this paper
• Quantitative Modeling of In Vitro Data Using an Adverse Outcome Pathway for the Risk Assessment of Decreased Lung Function in Humans.

  2024cites this paper
• Crowdsourcing AOP development: Leveraging the thesis literature review to identify knowledge gaps and facilitate research translation

  2024cites this paper
• Integration of MUTZ-Langerhans cells into a 3D full-thickness skin equivalent and influences of serum reduction and undefined medium supplements on differentiation.

  2024cites this paper
• GARD™skin and GARD™potency: A proof-of-concept study investigating applicability domain for agrochemical formulations.

  2024cites this paper
• A regression analysis using simple descriptors for multiple dermal datasets: Going from individual membranes to the full skin

  2023cites this paper
• The Frontline of Alternatives to Animal Testing: Novel In vitro Skin Model Application in Drug Development and Evaluation.

  2023cites this paper
• Molecular Adverse Outcome Pathways: towards the implementation of transcriptomics data in risk assessments

  2023cites this paper
• Pre-validation study of spectrophotometric direct peptide reactivity assay (Spectro-DPRA) as a modified in chemico skin sensitization test method

  2022cites this paper
• Mapping Mechanistic Pathways of Acute Oral Systemic Toxicity Using Chemical Structure and Bioactivity Measurements

  2022cites this paper
• An integrated pathway based on in vitro data for the human hazard assessment of nanomaterials.

  2020influential citation
• Proteomic analysis of haptenation by skin sensitisers: Diphencyprone and ethyl acrylate.

  2020cites this paper
• Mathematical modelling of contact dermatitis from nickel and chromium

  2019cites this paper
• Advancing Computational Toxicology in the Big Data Era by Artificial Intelligence: Data-Driven and Mechanism-Driven Modeling for Chemical Toxicity.

  2019cites this paper
• Developmental Neurotoxicity: An Update.

  2019cites this paper
• Integrated Approaches to Testing and Assessment

  2019cites this paper
• Identification of Contact Allergens by In Vitro Cell Culture-Based Methods

  2019cites this paper
• Human skin equivalents cultured under hypoxia display enhanced epidermal morphogenesis and lipid barrier formation

  2019cites this paper
• Regulatory acceptance of in silico approaches for the safety assessment of cosmetic-related substances

  2019cites this paper
• Skin and respiratory chemical allergy: confluence and divergence in a hybrid adverse outcome pathway.

  2018cites this paper
• Non-animal methods to predict skin sensitization (II): an assessment of defined approaches**

  2018cites this paper
• The Adverse Outcome Pathway: A Multifaceted Framework Supporting 21st Century Toxicology.

  2018cites this paper
• Intra- and inter-laboratory reproducibility and predictivity of the HaCaSens assay: A skin sensitization test using human keratinocytes, HaCaT.

  2018cites this paper
• Using Transition State Modeling To Predict Mutagenicity for Michael Acceptors

  2018cites this paper
• The Impact of Novel Assessment Methodologies in Toxicology on Green Chemistry and Chemical Alternatives

  2018cites this paper
• Harvesting the promise of AOPs: An assessment and recommendations

  2018cites this paper
• Using 2D Structural Alerts to Define Chemical Categories for Molecular Initiating Events

  2018cites this paper
• Approaches to Reconsider Literature on Physiological Effects of Environmental Change: Examples From Ocean Acidification Research

  2018cites this paper
• Intégration des modèles in vitro dans la stratégie d'évaluation de la sensibilisation cutanée

  2018cites this paper
• Advancing the adverse outcome pathway framework—An international horizon scanning approach

  2017cites this paper
• The T Cell Response to the Contact Sensitizer Paraphenylenediamine Is Characterized by a Polyclonal Diverse Repertoire of Antigen-Specific Receptors

  2017cites this paper
• Determination of Protein Haptenation by Chemical Sensitizers Within the Complexity of the Human Skin Proteome

  2017cites this paper
• Intra-and inter-laboratory reproducibility and predictivity of the HaCaSens assay : A skin sensitization test using human keratinocytes

  2017cites this paper
• Practical approaches to adverse outcome pathway development and weight‐of‐evidence evaluation as illustrated by ecotoxicological case studies

  2017cites this paper
• The role of glutathione in Allergic Contact Dermatitis

  2017cites this paper
• Structure-Potency Relationships for Epoxides in Allergic Contact Dermatitis.

  2017cites this paper
• In vitro study of putative genomic biomarkers of nephrotoxicity through differential gene expression using gentamicin

  2017cites this paper
• Adverse outcome pathways: a concise introduction for toxicologists

  2017cites this paper
• Effect of Repeated Daily Dosing with 2,4-Dinitrochlorobenzene on Glutathione Biosynthesis and Nrf2 Activation in Reconstructed Human Epidermis.

  2016cites this paper
• How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory Toxicology

  2016cites this paper
• Mechanistic Understanding of Contact Allergy

  2016cites this paper
• Adverse Outcome Pathways—Organizing Toxicological Information to Improve Decision Making

  2016cites this paper
• Integrated Approaches to Testing and Assessment.

  2016cites this paper
• Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 2. The biological variability of the murine Local Lymph Node Assay (LLNA) for skin sensitisation.

  2016cites this paper
• State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies

  2016cites this paper
• Analysis of the Local Lymph Node Assay (LLNA) variability for assessing the prediction of skin sensitisation potential and potency of chemicals with non-animal approaches.

  2016cites this paper
• A History of the Molecular Initiating Event.

  2016cites this paper
• Limitations of toxicity characterization in life cycle assessment: Can adverse outcome pathways provide a new foundation?

  2016cites this paper
• Ionotropic GABA receptor antagonism-induced adverse outcome pathways for potential neurotoxicity biomarkers.

  2015cites this paper
• Systems Biology and Synthetic Biology: A New Epoch for Toxicology Research

  2015cites this paper
• Probabilistic hazard assessment for skin sensitization potency by dose–response modeling using feature elimination instead of quantitative structure–activity relationships

  2015cites this paper
• The Neural Progenitor Cell (NPC) Niche in the Adult Brain Provides a Target for Neurotoxicity: A Putative Adverse Outcome Pathway for ROS-Induced NPC Dysfunction with Higher Sensitivity During Aging

  2015cites this paper
• New concepts in cutaneous allergy

  2015cites this paper
• Photoprotection in changing times – UV filter efficacy and safety, sensitization processes and regulatory aspects

  2015cites this paper
• Integrated Testing Strategies (ITS) for safety assessment.

  2015cites this paper
• Adverse Outcome Pathways for Regulatory Applications: Examination of Four Case Studies With Different Degrees of Completeness and Scientific Confidence.

  2015cites this paper
• Alternative methods for regulatory toxicology – a state-of-the-art review

  2014cites this paper
• Avances en la evaluación de la sensibilización dérmica mediante métodos alternativos

  2014cites this paper
• Three-Dimensional Human Epidermal Skin Models and Skin Explants

  2014cites this paper
• Defining molecular initiating events in the adverse outcome pathway framework for risk assessment.

  2014cites this paper
• Integrated Testing Strategies ( ITS ) for Safety Assessment 1

  2014cites this paper
• Stable isotope labeling method for the investigation of protein haptenation by electrophilic skin sensitizers.

  2014cites this paper
• How Adverse Outcome Pathways Can Aid the Development and How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory Use of Computational Prediction Models for Regulatory Toxicology Toxicology

  year unknowncites this paper